| - SMTL ID
- 3ztc.1
- Ligands
- (4R)-N-(BIPHENYL-4-YLMETHYL)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-L-PROLINAMIDE
- Polypeptides
- TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
- Oligo-state
- hetero-1-1-1-mer
|
| - SMTL ID
- 3ztc.2
- Ligands
- (4R)-N-(BIPHENYL-4-YLMETHYL)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-L-PROLINAMIDE
- Polypeptides
- TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
- Oligo-state
- hetero-1-1-1-mer
|
| - SMTL ID
- 3ztc.3
- Ligands
- (4R)-N-(BIPHENYL-4-YLMETHYL)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-L-PROLINAMIDE
- Polypeptides
- TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
- Oligo-state
- hetero-1-1-1-mer
|
| - SMTL ID
- 3ztc.4
- Ligands
- (4R)-N-(BIPHENYL-4-YLMETHYL)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-L-PROLINAMIDE
- Polypeptides
- TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1; VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR
- Oligo-state
- hetero-1-1-1-mer
|